Skip to main content
Clinical Trials/NCT00051220
NCT00051220
Completed
Phase 1

One-Session Treatment for Specific Phobias in Children

Virginia Polytechnic Institute and State University2 sites in 2 countries150 target enrollmentOctober 2001

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Phobic Disorders
Sponsor
Virginia Polytechnic Institute and State University
Enrollment
150
Locations
2
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.

Detailed Description

Children with specific phobias may experience academic, social, and personal distress, as well as interference in day-to-day activities. One-Session Treatment has been found a rapid and effective treatment for adults with phobic disorders. However, its utility in the treatment of childhood phobia has not been examined. Participants are randomly assigned to 1 of 3 groups: a one-session treatment group, an education/support group, and a waitlist control group. The one-session treatment group is directly exposed to a phobia object or situation during a 3-hour treatment session. In the education/support group, children are given information about fear and phobias and are taught how to deal with them through workbook activities. Children who participate in the one-session treatment group or the education/support group are assessed 1 week post-treatment and again after 6 months. Participants with improved symptoms have a 1-year follow-up. Participants with phobias that persist at 6 months are encouraged to participate in alternative treatment. Waitlist control participants are assessed pre-treatment and 1 month post-treatment. Those who continue to have phobias at the 1-month assessment are randomly assigned to 1 of the 2 active treatments.

Registry
clinicaltrials.gov
Start Date
October 2001
End Date
September 2006
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Thomas H. Ollendick

Professor

Virginia Polytechnic Institute and State University

Eligibility Criteria

Inclusion Criteria

  • Primary diagnosis of specific phobia disorder

Exclusion Criteria

  • Mental retardation
  • Developmental disabilities
  • Suicide threat

Outcomes

Primary Outcomes

Not specified

Study Sites (2)

Loading locations...

Similar Trials